Portland Hill Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Portland Hill Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-55	Closed	-$28K	–	41
2023 Q3	$28K	Hold	55	–	–	0.07%	36
2023 Q2	$28K	Buy	+55	New	+$29.7K	0.07%	37

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Portland Hill Asset Management's TMO Position: Q4 2023 in Review

Portland Hill Asset Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 55 shares — an estimated $28K sold.

Portland Hill Asset Management first reported a position in TMO in Q2 2023 and held it in 2 quarters. The position peaked at $28K in Q3 2023. 2,490 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Portland Hill Asset Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Portland Hill Asset Management sold 55 Thermo Fisher Scientific shares in Q4 2023, an estimated $28K.
Portland Hill Asset Management first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 2 quarters.
Portland Hill Asset Management's Thermo Fisher Scientific position peaked at $28K in Q3 2023.
2,490 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Portland Hill Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.